tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

SoftMedx Healthcare Resumes Trading After Addressing Regulatory Concerns

Story Highlights
  • SoftMedx Healthcare Limited resumes trading on the Hong Kong Stock Exchange after a suspension since 2017.
  • The resumption follows regulatory concerns over a past transaction and requires fulfillment of specific conditions.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
SoftMedx Healthcare Resumes Trading After Addressing Regulatory Concerns

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

An update from China Wah Yan Healthcare ( (HK:0648) ) is now available.

SoftMedx Healthcare Limited has announced the resumption of trading of its shares on the Stock Exchange of Hong Kong, following a suspension initiated in November 2017 due to concerns raised by the Securities and Futures Commission. The resumption is contingent upon the company fulfilling specific conditions, including the publication of announcements and a follow-up review by an independent consultant to ensure the implementation of internal control recommendations. The suspension was originally due to issues surrounding a transaction involving New Ray Medicine International Holding Limited, where the integrity and conduct of the company’s management were questioned.

More about China Wah Yan Healthcare

Current Market Cap: HK$123.9M

For a thorough assessment of 0648 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1